<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05011682</url>
  </required_header>
  <id_info>
    <org_study_id>2021/230363</org_study_id>
    <nct_id>NCT05011682</nct_id>
  </id_info>
  <brief_title>The Effect of 'Medical Nutrition Therapy' on Post-bariatric Hypoglycemia 2-4 Years After Gastric Bypass Surgery</brief_title>
  <official_title>The Effect of Nutrition and Medical Therapy on Post-bariatric Hypoglycemia Patients 2-4 Years After a Roux-en-Y Gastric Bypass: a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helse Nord-Trøndelag HF</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Helse Nord-Trøndelag HF</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a pilot study to explore the effect of 'medical nutritional therapy' in patients&#xD;
      diagnosed with post-bariatric hypoglycemia (PBH), 2-4 years after gastric bypass surgery. The&#xD;
      study is largely inspired by the findings presented in the meta-analyses from Joslin Diabetes&#xD;
      Center, where a treatment strategy is proposed to reduce the symptoms of PBH. This treatment&#xD;
      strategy is mainly based on clinical observations and experience, while there is little or no&#xD;
      objective data to support that this strategy improves PBH. The data from this pilot study can&#xD;
      then be used to set up larger studies where a conclusion on treatment of PBH may be drawn.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">August 27, 2021</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Participants are their own controls. All participants will follow their usual diet in the first 2 weeks, and then during the next 2 weeks the 10-point nutrition plan according to Joslin Diabetes Center.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>blood sugar variation</measure>
    <time_frame>4 weeks</time_frame>
    <description>measured by continuous blood glucose monitor</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Hypoglycemia</condition>
  <condition>Obesity, Morbid</condition>
  <arm_group>
    <arm_group_label>Joslin Diabetes Senter nutrition</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>all participants will first follow their own usual diet (2 weeks) and then the Joslin Diabetes Senter nutrition plan (2 weeks)</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Regular diet</intervention_name>
    <description>participant's usual diet during 2 weeks</description>
    <arm_group_label>Joslin Diabetes Senter nutrition</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>10-point nutrition plan</intervention_name>
    <description>controlled portions of low glycemic index carbohydrates, avoidance of rapidly absorbed carbohydrates, adjustment of timing of meals and snacks, and attention to personal and cultural barriers to implementation</description>
    <arm_group_label>Joslin Diabetes Senter nutrition</arm_group_label>
    <other_name>Joslin Diabetes Senter nutrition plan</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patient in Nord-Trøndelag 2-4 years after Roux-en-y gastric bypass surgery&#xD;
&#xD;
          -  visits Namsos outpatient clinic for follow-up.&#xD;
&#xD;
          -  having at least 3 symptoms of hypoglycemia presented in the dumping severity scale&#xD;
             (DSS).&#xD;
&#xD;
          -  at least one of these symptoms must be a neuroglycopenic symptom&#xD;
&#xD;
          -  all these symptoms have an intensity of 2 or 3 on DSS.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  severe surgery-related complication&#xD;
&#xD;
          -  revisional surgery&#xD;
&#xD;
          -  life threatening health conditions.&#xD;
&#xD;
          -  diabetes mellitus or other metabolic diseases&#xD;
&#xD;
          -  pregnancy or breast feeding&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bodil Landstad, phd</last_name>
    <role>Study Director</role>
    <affiliation>Helse Nord-Trøndelag HF</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Siren Nymo, phd</last_name>
    <phone>+47 99514188</phone>
    <email>siren.nymo@ntnu.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anders Svare, md phd</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Obesity Outpatient Clinic, Surgical Clinic, Nord-Trøndelag Hospital Trust, Hospital of Namsos</name>
      <address>
        <city>Namsos</city>
        <state>Trøndelag</state>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ann Karin Torgersen</last_name>
      <email>AnnKarin.Torgersen@helse-nordtrondelag.no</email>
    </contact>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 17, 2021</study_first_submitted>
  <study_first_submitted_qc>August 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 18, 2021</study_first_posted>
  <last_update_submitted>August 17, 2021</last_update_submitted>
  <last_update_submitted_qc>August 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Gastric bypass</keyword>
  <keyword>Diet therapy</keyword>
  <keyword>Blood sugar variation</keyword>
  <keyword>Quality of Life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoglycemia</mesh_term>
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

